Pemetrexed Teva

Medicinal product

(Invented) name

Pemetrexed Teva

Active substance (s)

Pemetreksedas

Strength

25 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01BA04, Pemetrexed

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2017-06-13

Date of renewal

Documents

4090 Pemetrexed Teva konc inf PCS PL 2021_03_26.docx

4090_1_3 Pakuotės lapelis 2021_03_26.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

DE/H/4630/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Pemetreksedas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
64662	79148	1079148	flakonas	4 ml N1		Receptinis	LT/1/17/4090/001	Netiekiama	-	-	No	-	-
68550	83130	1083130	flakonas	20 ml N1		Receptinis	LT/1/17/4090/002	Netiekiama	-	-	No	-	-
68551	83131	1083131	flakonas	40 ml N1		Receptinis	LT/1/17/4090/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-30	Išregistruotas
2017-06-13	Registruotas